Organic & Biomolecular Chemistry
Paper
4.48 (s, 2H), 4.02 (t, J = 6.8 Hz, 2H), 2.41 (s, 3H), 1.65–1.52 (m,
2H), 1.42–1.37 (m, 2H), 0.95 (t, J = 7.4 Hz, 3H). 13C NMR
(125 MHz, CDCl3) δ 166.6, 145.7, 144.7, 136.4, 133.8, 129.6,
129.5, 129.2, 128.7, 128.5, 121.5, 65.4, 55.1, 30.5, 21.6, 19.2,
13.7. HRMS (ESI) calcd for C21H25O4S (M + H)+: 373.1474;
found: 373.1462.
(Z)-Ethyl 3-(p-tolyl)-2-(tosylmethyl)acrylate (3da). 1H NMR
(500 MHz, CDCl3) δ 7.90 (s, 1H), 7.73 (d, J = 8.3 Hz, 2H), 7.42
(d, J = 8.1 Hz, 2H), 7.28 (d, J = 8.1 Hz, 2H), 7.18 (d, J = 8.0 Hz,
2H), 4.49 (s, 2H), 4.04 (q, J = 7.1 Hz, 2H), 2.42 (s, 3H), 2.37 (s,
3H), 1.22 (t, J = 7.1 Hz, 3H). 13C NMR (125 MHz, CDCl3)
δ 166.7, 146.0, 144.6, 140.1, 136.6, 131.0, 129.6, 129.4, 129.4,
128.6, 120.3, 61.4, 55.3, 21.6, 21.4, 14.1. HRMS (ESI) calcd for
C20H23O4S (M + H)+: 359.1317; found: 359.1304.
(Z)-Methyl 3-(2-methoxyphenyl)-2-(tosylmethyl)acrylate (3ea).
1H NMR (500 MHz, CDCl3) δ 8.05 (s, 1H), 7.69 (d, J = 8.3 Hz,
2H), 7.58 (dd, J = 7.6, 0.9 Hz, 1H), 7.37–7.30 (m, 1H), 7.24 (d,
J = 8.0 Hz, 2H), 6.95 (t, J = 7.4 Hz, 1H), 6.83 (d, J = 8.3 Hz, 1H),
4.44 (s, 2H), 3.79 (s, 3H), 3.63 (s, 3H), 2.41 (s, 3H). 13C NMR
(125 MHz, CDCl3) δ 167.0, 157.3, 144.4, 142.2, 136.5, 131.1,
129.8, 129.5, 128.5, 122.7, 121.0, 120.6, 110.5, 55.5, 55.4, 52.2,
21.6. HRMS (ESI) calcd for C19H21O5S (M + H)+: 361.1110;
found: 361.1099.
Scheme 2 Proposed preliminary mechanisms.
(Z)-Methyl 3-(2-chlorophenyl)-2-(tosylmethyl)acrylate (3ia). 1H
NMR (500 MHz, CDCl3) δ 7.99 (s, 1H), 7.69 (d, J = 8.3 Hz, 2H),
7.65–7.60 (m, 1H), 7.40–7.24 (m, 5H), 4.37 (s, 2H), 3.65 (s, 3H),
2.42 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 166.4, 144.7, 142.8,
136.3, 134.1, 132.3, 130.5, 130.0, 129.7, 129.7, 128.4, 127.0,
123.3, 55.0, 52.5, 21.6. HRMS (ESI) calcd for C18H18ClO4S (M +
H)+: 365.0614; found: 365.0603.
NMR spectra were recorded at 25 °C in CDCl3 at 500 and
125 MHz, respectively, with TMS as the internal standard.
Chemical shifts (δ) are expressed in ppm and coupling con-
stants J are given in Hz. High resolution mass spectra (HRMS)
were obtained on a TOF MS instrument with an ESI source.
Baylis–Hillman acetates were prepared by the reported
procedure.11
General procedure for the synthesis of allyl aryl sulfone
derivatives 3. To a flask containing the Baylis–Hillman acet-
ates 1 (0.5 mmol), sulfonylhydrazides 2 (0.6 mmol), and tetra-
butylammonium iodide (0.1 mmol) in H2O (3 mL), TBHP
(70% aqueous solution) (1.0 mmol) was added. The suspen-
sion was stirred at 80 °C for 0.5 h. The mixture was then
extracted with AcOEt (4 × 10 mL) and the extract was washed
with brine, dried (anh. Na2SO4), and concentrated. The
residual was treated with silica gel chromatography (ethyl
acetate–petroleum ether) to give allyl aryl sulfones 3. The
characterization data for known compounds (3aa,5 3fa,4a
3ga,4b 3ha,5 3ka,4b 3la,4a 3ma,5 3na,4b 3ab,5 3hb,5 3lb5) are pro-
vided in the ESI.†
(Z)-Ethyl 3-phenyl-2-(tosylmethyl)acrylate (3ba). 1H NMR
(500 MHz, CDCl3) δ 7.91 (s, 1H), 7.71 (d, J = 8.3 Hz, 2H),
7.49–7.42 (m, 2H), 7.38–7.33 (m, 3H), 7.25 (d, J = 8.0 Hz, 2H),
4.48 (s, 2H), 4.07 (q, J = 7.1 Hz, 2H), 2.41 (s, 3H), 1.24 (t, J =
7.1 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 166.5, 145.8, 144.7,
136.4, 133.8, 129.6, 129.5, 129.2, 128.7, 128.5, 121.5, 61.5, 55.1,
21.6, 14.1. HRMS (ESI) calcd for C19H21O4S (M + H)+: 345.1161;
found: 245.1150.
(Z)-Methyl
3-(4-isopropylphenyl)-2-(tosylmethyl)acrylate
(3ja). 1H NMR (500 MHz, CDCl3) δ 7.91 (s, 1H), 7.73 (dd, J =
8.4, 1.7 Hz, 2H), 7.45 (d, J = 8.1 Hz, 2H), 7.28–7.24 (m, 4H),
4.52 (s, 2H), 3.60 (s, 3H), 2.95–2.89 (m, 1H), 2.43 (s, 3H), 1.28
(s, 3H), 1.27 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 167.1, 151.0,
146.3, 144.6, 136.4, 131.2, 129.6, 128.6, 126.8, 120.0, 55.3, 52.3,
34.0, 23.8, 21.6. HRMS (ESI) calcd for C21H25O4S (M + H)+:
373.1474; found: 373.1462.
(Z)-Ethyl 3-(4-chlorophenyl)-2-((phenylsulfonyl)methyl)acrylate
(3gb). 1H NMR (500 MHz, CDCl3) δ 7.89 (s, 1H), 7.86 (d, J =
7.4 Hz, 2H), 7.62 (t, J = 7.5 Hz, 1H), 7.53–7.43 (m, 4H), 7.35 (d,
J = 8.5 Hz, 2H), 4.45 (s, 2H), 4.04 (q, J = 7.1 Hz, 2H), 1.22 (t, J =
7.1 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 166.1, 144.5, 139.3,
135.7, 133.8, 132.1, 130.5, 129.0, 129.0, 128.4, 121.7, 61.6, 55.0,
14.0. HRMS (ESI) calcd for C18H18ClO4S (M + H)+: 365.0614;
found: 365.0602.
(Z)-Methyl 2-(((4-bromophenyl)sulfonyl)methyl)-3-phenyl acry-
late (3ac). 1H NMR (500 MHz, CDCl3) δ 7.94 (s, 1H), 7.69–7.62
(m, 2H), 7.61–7.55 (m, 2H), 7.43–7.36 (m, 5H), 4.52 (s, 2H),
3.68 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 166.7, 146.4, 138.1,
133.5, 132.3, 130.1, 129.7, 129.2, 129.0, 128.8, 120.8, 54.9, 52.5.
HRMS (ESI) calcd for C17H16BrO4S (M + H)+: 394.9953; found:
394.9939.
(Z)-Butyl 3-phenyl-2-(tosylmethyl)acrylate (3ca). 1H NMR
(Z)-Methyl
2-(((4-bromophenyl)sulfonyl)methyl)-3-(4-chloro-
(500 MHz, CDCl3) δ 7.90 (s, 1H), 7.70 (d, J = 8.3 Hz, 2H), phenyl)acrylate (3fc). 1H NMR (500 MHz, CDCl3) δ 7.89 (s, 1H),
7.49–7.42 (m, 2H), 7.37–7.32 (m, 3H), 7.25 (d, J = 8.0 Hz, 2H), 7.71–7.65 (m, 2H), 7.65–7.60 (m, 2H), 7.45–7.35 (m, 4H), 4.46
This journal is © The Royal Society of Chemistry 2013
Org. Biomol. Chem., 2013, 11, 1739–1742 | 1741